Re: Comments on ‘High-intensity statins are associated with improved clinical activity of programmed cell death protein 1 inhibitors in malignant pleural mesothelioma and advanced non–small cell lung cancer patients’

Luca Cantini, Federica Pecci, Floris Dammeijer, Joachim G.J.V. Aerts, Rossana Berardi*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)267-269
Number of pages3
JournalEuropean Journal of Cancer
Early online date18 Jun 2021
Publication statusPublished - Aug 2021

Cite this